scholarly article | Q13442814 |
P2093 | author name string | G. Kunos | |
S. Grant | |||
P. Dent | |||
M. Spector | |||
R. Mikkelsen | |||
W. D. Jarvis | |||
K. L. Auer | |||
P. Hylemon | |||
P2860 | cites work | Cancer Research | Q326097 |
Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro | Q28211916 | ||
Raf-1 protein kinase is required for growth of induced NIH/3T3 cells | Q28265128 | ||
PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo | Q28609356 | ||
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 | ||
Liver regeneration | Q29614743 | ||
Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro | Q30452723 | ||
Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway | Q34889125 | ||
Liver regeneration 3: Regulation of signal transduction during liver regeneration. | Q40993734 | ||
Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion | Q41074846 | ||
The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase | Q41157362 | ||
Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. | Q41218044 | ||
Phosphorylation of Raf by ceramide-activated protein kinase | Q41270560 | ||
Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses | Q41382443 | ||
Inverse regulation of hepatic alpha 1B- and beta 2-adrenergic receptors. Cellular mechanisms and physiological implications | Q45082016 | ||
Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells | Q45096564 | ||
Reduction of voltage-dependent Mg2+ blockade of NMDA current in mechanically injured neurons | Q45101676 | ||
Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors | Q46175993 | ||
Rapid inverse changes in alpha 1B- and beta 2-adrenergic receptors and gene transcripts in acutely isolated rat liver cells | Q67491080 | ||
Programmed cell death induced by ceramide | Q70619078 | ||
Ceramide activates the stress-activated protein kinases | Q71742988 | ||
α 1 -Adrenoceptor Activation Increases Ecto-5′-Nucleotidase Activity and Adenosine Release in Rat Cardiomyocytes by Activating Protein Kinase C | Q72113010 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mitogen-activated protein kinase kinases | Q6593810 |
P304 | page(s) | 9-14 | |
P577 | publication date | 1997-07-01 | |
1997-07-21 | |||
P1433 | published in | FEBS Letters | Q1388051 |
P1476 | title | Positive and negative regulation of JNK1 by protein kinase C and p42(MAP kinase) in adult rat hepatocytes | |
Positive and negative regulation of JNK1 by protein kinase C and p42MAP kinase in adult rat hepatocytes | |||
P478 | volume | 412 |
Q74510339 | Activation of p42/p44 mitogen-activated protein kinase by angiotensin II, vasopressin, norepinephrine, and prostaglandin F2alpha in hepatocytes is sustained, and like the effect of epidermal growth factor, mediated through pertussis toxin-sensitive |
Q41702903 | Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family |
Q44863595 | Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.Miko |
Q44675180 | Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process |
Q77363665 | Inhibition of rat hepatocyte proliferation by transforming growth factor beta and glucagon is associated with inhibition of ERK2 and p70 S6 kinase |
Q34991305 | Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations |
Q48025656 | Pervanadate inhibits mitogen‐activated protein kinase kinase‐1 in a p38MAPK‐dependent manner |
Q43919066 | Retinoic acid inhibits hepatic Jun N-terminal kinase-dependent signaling pathway in ethanol-fed rats |
Q77936301 | Skp2 induction and phosphorylation is associated with the late G1 phase of proliferating rat hepatocytes |
Q33957440 | The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells |
Q28574430 | The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes |
Q36900115 | The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide |
Q44849046 | The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib |
Q33959204 | The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes |
Q73401718 | The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis |
Q40756993 | Treatment of mice with EGF and orthovanadate activates cytoplasmic and nuclear MAPK, p70S6k, and p90rsk in the liver. |
Search more.